Madryn asset management releases evidence that somalogic ran a flawed and incomplete review of alternatives

New york--(business wire)--madryn asset management, lp (collectively with its affiliates, “madryn” or “we”), a holder of approximately 4.2% of the outstanding common stock of somalogic, inc. (“somalogic” or the “company”) (nasdaq: slgc), today disclosed that the transaction committee of the company's board of directors (the “transaction committee”) did not pursue a substantive dialogue with laboratory corporation of america holdings (“labcorp”) (nyse: lh) – one of the industry's most logical st.
LH Ratings Summary
LH Quant Ranking